你好!欢迎访问 登录|立即注册

0576-88813233

|
浙江省台州市椒江开发大道东段288号万达广场2号楼
0576-88813233
0576-88670057
sales@dxymsy.com
合作客户/Partner
当前位置:885566威尼斯产品

盐酸伊立替康三水合物

盐酸伊立替康三水合物 136572-09-3
规格 价格 库存 数量
大包装询价 加入购物车
如您需要更多数量的报价,请点击立即获取报价或者通过电子邮件sales@dxymsy.com把您需要的数量信息提交给我们我们会在第一时间回复您,谢谢!
产品信息
产品名称:盐酸伊立替康三水合物 纯度:98% min
CAS NO:136572-09-3 溶解度:Soluble in DMSO
分子式:C33H38N4O6.HCl.3H2O 包装:可按客户要求包装。
分子量:677.18 贮存:Store at -20℃ 3 years
质量控制
备注说明

盐酸伊立替康三水合物Irinotecan hydrochloride trihydrate 是一种水溶性的拓扑异构酶 I (topoisomerase I) 抑制剂,具有抗肿瘤活性。Irinotecan hydrochloride trihydrate is a topoisomerase I inhibitor. Irinotecan inhibits the growth of LoVo and HT-29 cells, with IC50s of 15.8 ± 5.1 and 5.17 ± 1.4 μM, respectively, and induces similar amounts of cleavable complexes in both in LoVo and HT-29 cells[2]. Irinotecan suppresses the proliferation of human umbilical vein endothelial cells (HUVEC), with an IC50 of 1.3 μM[3].Irinotecan (CPT-11, 5 mg/kg) significantly inhibits the growth of tumors by intratumoral injection daily for 5 days, on two consecutive weeks in rats, and such effects also occur via continuous intraperitoneal infusion by osmotic minipump into mice. However, Irinotecan (10 mg/kg) shows no effect on the growth of tumor by i.p[1]. Irinotecan (CPT-11, 100-300 mg/kg, i.p.) apparently suppresses tumor growth of HT-29 xenografts in athymic female mice by day 21. The two groups of Irinotecan (125 mg/kg) plus TSP-1 (10 mg/kg per day) or Irinotecan (150 mg/kg) in combination TSP-1 (20 mg/kg per day) are nearly equally effective and inhibit tumor growth 84% and 89%, respectively, and both are more effective than Irinotecan alone at doses of 250 and 300 mg/kg[3].

参考文献

[1]. 

[2]. 

[3]. 

版权所有 Copyright(C) 2018-2024 台州市885566威尼斯生物技术有限公司

技术支持:kerui  浙ICP备09021343号-1
公司所列产品中涉及到专利,只供研发使用,不做销售;管制产品将严格遵守中国法律和购买客户国法律的规定销售,所有产品都不适用于人用 如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。
网站地图